In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Nevada has enacted a first‑in‑the‑nation law permitting insurers to sell homeowners policies that exclude wildfire coverage, a move supporters say could help stabilize premiums but critics warn may leave homeowners financially devastated. The policy shift positions Nevada as a testing ground for potential nationwide changes, raising major implications for real estate, mortgage, and insurance professionals as lenders, high‑risk communities, and regulators navigate the evolving landscape.
Tampa Bay’s office sector just delivered its most powerful year in nearly a decade, according to JLL’s Q4 2025 report. With more than 600,000 square feet of positive net absorption, falling vacancies, shrinking inventory, and major tenants like Fisher Investments and GEICO locking in massive leases, the region is emerging as one of the nation’s strongest post‑recovery office markets. The surge in demand for high‑quality space is driving rents up, tightening supply, and setting the stage for continued momentum into 2026.
The Consumer Financial Protection Bureau has proposed new updates to the Nationwide Mortgage Licensing System and Registry, expanding data collection, tightening verification standards, and refreshing record‑retention rules. These changes aim to strengthen background checks, enhance regulatory oversight, and align the system with federal requirements—impacting both current and aspiring mortgage loan originators nationwide.
Nevada has become the first state to let insurers sell homeowners policies that exclude wildfire coverage — a dramatic shift that could reshape insurance pricing across the West. Supporters say the move may lower premiums and spark innovation, while critics warn it could leave homeowners exposed to devastating losses. As regulators and insurers nationwide watch closely, the experiment could have major implications for real estate, mortgages, and insurance markets.
After years of soaring premiums and insurer failures, Florida lawmakers are rolling out a new slate of reforms aimed at finally delivering relief to homeowners. From cracking down on profit‑sharing affiliates to unveiling hidden rate factors and rewarding claim‑free residents, these proposals could reshape the state’s insurance landscape — and bring real savings to property owners and real estate professionals alike.
With traditional CRE lending slowing nationwide, C‑PACE financing is surging to all‑time highs — including a record‑setting $465 million loan for a major D.C. redevelopment. Backed by long repayment terms, fixed rates, and tax‑assessment security, C‑PACE is rapidly becoming a preferred tool for funding energy efficiency, resiliency upgrades, and even large‑scale project recapitalizations. Major players like Nuveen Green Capital and Peachtree Group are driving billions in new volume as 40 states adopt the program, signaling a major shift in how commercial real estate projects are financed.
